Send the following on WhatsApp
Continue to Chathttps://it.marketscreener.com/quotazioni/azione/3D-MEDICINES-INC-147680264/attualita/Alphamab-Oncology-e-3Dmedicines-stipulano-un-accordo-di-licenza-con-Glenmark-per-KN035-45807498/?utm_source=whatsapp&utm_medium=social&utm_campaign=share